Next Generation Sequencing (NGS) coupled with Pillar Biosciences' SLIMamp technology offers the clinical laboratory developer unique advantages in workflow, sensitivity and cost structure. With a recent ISO 13845:2016 certification for design,
development, manufacture and distribution of products for the clinical oncology laboratory, a comprehensive quality management system has been successfully implemented.
Innovation & Quality
Pillar Biosciences actively develops NGS-based in vitro diagnostics. Contact us regarding customization of our offerings to meet your unique needs.